Is the Association between Cigarette Smoking and Breast Cancer Modified by Genotype? A Review of Epidemiologic Studies and Meta-analysis
- 1 April 2006
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 15 (4) , 602-611
- https://doi.org/10.1158/1055-9965.epi-05-0853
Abstract
Epidemiologic studies have examined the association between cigarette smoking and breast cancer risk according to genotype with increasing frequency, commensurate with the growing awareness of the roles genes play in detoxifying or activating chemicals found in cigarette smoke and in preventing or repairing the damage caused by those compounds. To date, ∼50 epidemiologic studies have examined the association between smoking and breast cancer risk according to variation in genes related to carcinogen metabolism, modulation of oxidative damage, and DNA repair. Some of the findings presented here suggest possible effect modification by genotype. In particular, 14 epidemiologic studies have tended to show positive associations with long-term smoking among NAT2 slow acetylators, especially among postmenopausal women. Summary analyses produced overall meta–relative risk (RR) estimates for smoking of 1.2 [95% confidence interval (95% CI), 1.0-1.5] for rapid acetylators and 1.5 (95% CI, 1.2-1.8) for slow acetylators. After stratification by menopausal status, the meta-RR for postmenopausal slow acetylators was 2.4 (95% CI, 1.7-3.3), whereas similar analyses for the other categories showed no association. In addition, summary analyses produced meta-RRs for smoking of 1.1 (95% CI, 0.8-1.4) when GSTM1 was present and 1.5 (95% CI, 1.1-2.1) when the gene was deleted. Overall, however, interpretation of the available literature is complicated by methodologic limitations, including small sample sizes, varying definitions of smoking, and difficulties involving single nucleotide polymorphism selection, which likely have contributed to the inconsistent findings. These methodologic issues should be addressed in future studies to help clarify the association between smoking and breast cancer. (Cancer Epidemiol Biomarkers Prev 2006;15(4):602–11)Keywords
This publication has 82 references indexed in Scilit:
- MnSOD Val-9Ala Genotype, Pro- and Anti-oxidant Environmental Modifiers, and Breast Cancer Among Women on Long Island, New YorkCancer Causes & Control, 2005
- Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from PolandBreast Cancer Research and Treatment, 2005
- The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriersCarcinogenesis: Integrative Cancer Research, 2005
- Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands)Cancer Causes & Control, 2005
- Polymorphisms in XRCC1 Modify the Association between Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, Dietary Antioxidants, and Breast Cancer RiskCancer Epidemiology, Biomarkers & Prevention, 2005
- NAT2 slow acetylator genotype as an important modifier of breast cancer riskInternational Journal of Cancer, 2004
- Characterization of a major aromatic DNA adduct detected in human breast tissuesEnvironmental and Molecular Mutagenesis, 2002
- Structural Dimorphism in the Mitochondrial Targeting Sequence in the Human Manganese Superoxide Dismutase Gene: A Predictive Evidence for Conformational Change to Influence Mitochondrial Transport and a Study of Allelic Association in Parkinson's Disease: Volume226,Number 2 (1996), pages 561–565:Biochemical and Biophysical Research Communications, 1996
- A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancerMolecular Carcinogenesis, 1996
- The file drawer problem and tolerance for null results.Psychological Bulletin, 1979